On the basis of their susceptibility to ampicillin, strains of Haemophilus influenzae can be divided into three types: type 1 are normally susceptible strains, type 2 produce stable spheroplasts from low inocula, and type 3 are 38-lactamase producers. Because of the production of spheroplasts, standard broth and agar dilution techniques have failed to differentiate between the responses of type 2 and 3 strains to ampicillin, or to identify the superiority of cefuroxime over ampicillin against the 63-lactamase-producing strains. Disk susceptibility tests with heavily seeded plates were also difficult to interpret. To overcome these problems, we developed a medium that supports the growth of H. influenzae, but not survival of spheroplasts, thereby reducing the complicating influence of spheroplast formation. Utilization of the medium made it possible to identify 3-lactamase-producing strains via both minimal inhibitory concentration and disk susceptibility techniques, as well as the superiority of cefuroxime over ampicillin against such strains. In vivo experiments showed that cefuroxime and ampicillin are equally active against infections with type 1 and 2 strains, but that cefuroxime is superior to ampicillin against infections with type 3 (8-lactamase-producing strains.
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Until relatively recently, H. influenzae has remained remarkably stable in regard to its susceptibility to antibiotics (22). Ampicillin, chloramphenicol, and the tetracyclines have proved generally effective against the organism. However, over the last few years, an increasing number of reports have described the appearance of antibiotic-resistant strains (3, 5, 6, 8-10, 16, 19) .
Infection due to ampicillin-resistant strains of H. influenzae has become an increasingly serious and widespread problem (1, 4, 18) . The primary cause of ampicillin resistance appears to be the production of a fl-lactamase that is capable of hyrolyzing a number of penicillin and cephalosporin substrates (7, 13, 17 By using representative strains of the three types ofH. influenzae, we compared the activities of ampicillin and cefuroxime, a /3-lactamase-stable cephalosporin (14) . Tests have been carried out using a commercially available nutrient medium and a contrived medium of low osmolality in which the spheroplasts of H. influenzae fail to survive.
MATERIALS AND METHODS
Organisms. All studies were carried out using six strains of each type of H. influenzae. Isolates were all derived from clinical material and given to us by P. Cavanagh, Public Health Laboratory, Stafford, England.
Media. The nutrient broth was Oxoid no. 2 (osmolality, 260 mOsmol/kg). The nutrient agar was Oxoid blood agar base. Dextrose phosphate broth contained bacteriological peptone (Difco), 4 Cefuroxime was highly active against the type 3 strains, but spheroplasts were present at the high inoculum levels. Ampicillin, however, showed a response similar to that seen against the type 2 strains, with increased resistance at the low inoculum levels but, in the case of the type 3 strains, no spheroplast formation was observed.
(ii) Disk susceptibility tests. Two sets of nutrient agar plates were inoculated by flooding with 6-h broth cultures of H. influenzae, undiluted and diluted 1:100, respectively, and antibiotic disks (30 ,ug) of ampicillin and cefuroxime were applied to each. Type 1 strains gave large, clear zones with ampicillin and cefuroxime on the lightly seeded plates but hazy zones on the heavily seeded plates. With the type 2 strains, zones were difficult to read at both inoculum levels ( Fig. la and b) , spheroplasts being responsible for the hazy zones. Against the 18-lactamase-producing strain (Fig. 2a and  b) (i) MIC determinations. Ampicillin and cefuroxime showed high antibacterial activity against H. influenzae type 1 and 2 strains even at the high inoculum levels ( Table 2) . Against the type 3 strains, cefuroxime was highly active, whereas ampicillin resistance was still apparent (Table 2) .
(ii) Disk susceptibility tests. Ampicillin and cefuroxime disks produced clear zones against H. influenzae type 1 and 2 strains at both inoculum concentrations (Fig. 3a and b) . Against the ,3-lactamase-producing strain (Fig. 4a and b) , ampicillin showed reduced activity on the lightly seeded plate and no activity at the picillin, B-lactamase-producing strains of H. influenzae are easily recognized on this medium, both by MIC and disk susceptibility tests. The superior activity of cefuroxime over ampicillin against such strains is also readily evident.
The in vitro results correlate well with the in vivo findings, in which cefuroxime, equally active as ampicillin against the type 1 and 2 strains of H. influenzae, is superior in activity to ampicillin against the 8-lactamase-producing strain.
Cefuroxime should be an extremely useful ,Blactam antibiotic for treating infections caused by H. influenzae, irrespective of their susceptibility to ampicillin. 
